Marinova has announced new research collaborations with a number of Australia's leading universities and industry bodies.
In recent years, Australia has implemented measures to accelerate the growth of its marine bio-industries to meet rapidly growing global demand for efficacious and sustainable products.
"Marinova continues to collaborate with a wide range of outstanding research partners across the globe," said the company's Research Director, Dr Barbara Wimmer.
We are pleased to be expanding our research investment in 2026 by undertaking a suite of additional research projects here in Australia.
"These studies will leverage the world-class scientific capabilities of leading Australian universities. We now have projects underway at The University of Tasmania, Adelaide University, Flinders University, The University of Queensland and Griffith University."
Australia's Marine Bioproducts Cooperative Research Centre (MB-CRC) is a $270M consortium of industry, government and academic partners that drives collaborative research.
"Marinova is pleased to be a core industry partner in the MB-CRC and working alongside Australia's leading researchers to improve health outcomes," said Dr Wimmer.
Marinova has also partnered with Australia's Food and Beverage Accelerator (FaBA) to explore further innovations for the functional food and beverage category.
Marinova produces the highly sought-after Maritech range of fucoidans—the world's only high-purity, certified organic fucoidans with global regulatory acceptance.
Maritech's organic fucoidans are used as premium ingredients in top nutritional supplements, functional foods and beverages, skincare products and animal health solutions.
"In addition to Marinova's own extensive R&D programme, the company is also the supplier of choice to world-renowned research institutions," concluded Dr Wimmer.
The unrivalled quality and efficacy of Marinova's fucoidan extracts make them sought after for independent studies across the medical device and pharmaceutical sectors.